Kliniken und Institute


Abteilung Nuklearmedizin


Meller

Leitung

Direktor
Prof. Dr. Johannes Meller

Sekretariat

Telefon: +49 (0) 551 39-85 11
Fax: +49 (0) 551 39-85 26
E-Mail: ogerke@med.uni-goettingen.de

Patientenanmeldung

Telefon: +49 (0) 551 39-660 70

Anschrift

Robert-Koch-Str. 40
37075 Göttingen

Briefpostadresse

37099 Göttingen

Homepage

URL / Homepage www.nuklearmedizin.med.uni-goettingen.de

Downloads

PDF Publikationen 2015 2014 2013 2012 2011

PDF Qualitätsbericht 2013 2010

Ausgewählte Publikationen
  • Meller B, Bremmer F, Sahlmann CO, Hijazi S, Bouter C, Trojan L, Meller J, Thelen P (2015) Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy. EJNMMI Res. 2015 Dec;5(1):66. doi: 10.1186/s13550-015-0145-8
  • Sahlmann CO, Meller B, Bouter C, Ritter CO, Ströbel P, Lotz J, Trojan L, Meller J, Hijazi S (2015) Biphasic (68)Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma. Eur J Nucl Med Mol Imaging. 2016 May;43(5):898-905. doi: 10.1007/s00259-015-3251-y.
  • Hijazi S, Meller B, Leitsmann C, Strauss A, Meller J, Ritter CO, Lotz J, Schildhaus HU, Trojan L , Sahlmann CO (2015) Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography. Prostate. 2015 Dec;75(16):1934-40. doi: 10.1002/pros.23091.
  • Kretschmer L1, Bertsch HP, Bardzik P, Meller J, Hellriegel S, Thoms KM, Schön MP, Sahlmann CO (2014) The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):231-40. doi: 10.1007/s00259-014-2914-4.
  • Lemb J, Hüfner M, Meller B, Homayounfar K, Sahlmann C, Meller J (2013) How reliable is secondary risk stratification with stimulated thyroglobulin in patients with differentiated thyroid carcinoma? Results from a retrospective study. Nuklearmedizin. 2013;52(3):88-96. doi: 10.3413/Nukmed-0517-12-07.

Suchworte: Positronen-Emissions-Tomographie, Positronenemissionstomographie, PET, Radiojodtherapie, Radioimmuntherapie, Schilddrüse, Strahlenschutz, Szintigramm